Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,580.00up ₹23.00 (0.50%)BSE ₹4,564.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹4,557.00.
29 Oct: open ₹4,540.00, high ₹4,610.90, low ₹4,525.30
52-week range of traded prices to 29 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,74,208 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.02
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.48
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,20,05563.1% delivered
Torrent Pharmaceuticals analyst meets
91 filed, newest first. Page 2 of 2.
Nov 2021
11 Nov · Analysts
Oct 2021
Sep 2021
24 Sep · Analysts
18 Sep · Analysts
13 Sep · Analysts
Jul 2021
17 Jul · Analysts
Jun 2021
9 Jun · Analysts
3 Jun · Analysts
May 2021
26 May · Analysts
10 May · Analysts
Mar 2021
3 Mar · Analysts
Feb 2021
16 Feb · Analysts
Jan 2021
Dec 2020
2 Dec · Analysts
Nov 2020
21 Nov · Analysts
19 Nov · Analysts
Oct 2020
15 Oct · Analysts
Sep 2020
27 Sep · Analysts
Jul 2020
May 2020
20 May · Analysts
Jan 2020
20 Jan · Analysts
Oct 2019
18 Oct · Analysts
16 Oct · Analysts
Jul 2019
15 Jul · Analysts
May 2019
8 May · Analysts
Jan 2019
15 Jan · Analysts
Oct 2018
17 Oct · Analysts
Jul 2018
20 Jul · Analysts
May 2018
23 May · Analysts
Jan 2018
30 Jan · Analysts
Oct 2017
26 Oct · Analysts
Jul 2017
31 Jul · Analysts
14 Jul · Analysts
May 2017
19 May · Analysts
Jan 2017
24 Jan · Analysts
Oct 2016
Jul 2016
May 2016
21 May · Analysts